在新辅助疗法后,瘤微环境中的补充激活及其对胰腺癌结果的影响
Xiaofei Zhang1,2, Ruoxin Lan3, Yongjun Liu4,5
1Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA. xiaofei.zhang@nyulangone.org.
NPJ precision oncology
|March 3, 2025
概括
胰腺癌的新辅助疗法 (NAT) 改变了瘤细胞和微环境. 在瘤微环境中,NAT增强了补充基因,与更好的生存和免疫反应相关.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 新辅助疗法 (NAT) 是胰腺管腺癌 (PDAC) 的日益增长的标准.
- 了解NAT对癌细胞和瘤微环境 (TME) 的影响至关重要.
研究的目的:
- 研究NAT对PDAC癌细胞和TME的差异性影响.
- 在PDAC中识别与NAT反应相关的分子变化和生物标志物.
主要方法:
- 空间转录组学被用来比较NAT治疗和NAT-naïve PDAC中的基因表达.
- 单核RNA测序 (snRNA-seq) 用于验证.
主要成果:
- 在癌细胞中,NAT诱导了亡和抑制了癌细胞的增殖.
- 在TME中,NAT上调补充基因 (C1R,C1S,C3,C4B,C7),特别是癌症相关纤维细胞 (CAF) 中的C3.
- 增加的TME补充与增强的免疫调节CAFs,更多的CD4+T细胞,减少免疫疲劳和改善的生存率相关.
结论:
- 通过影响癌细胞和TME,NAT调节PDAC.
- 在NAT治疗的PDAC中,TME补充基因表达是预后和治疗反应的潜在生物标志物.
- 准补充通路可能为PDAC提供新的治疗策略.
更多相关视频
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
12.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
557
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461